Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2001
10/10/2001CN1316517A Leavo-dikotone reductase gene and its usage
10/10/2001CN1316516A Coded rpilk gene nucleotide sequence and its using method
10/10/2001CN1316513A Deeply fermented liquid culture medium for dephosphorizing bacteria
10/10/2001CN1316512A Process for preparing water-preserving granular stain of edible (medicinal)fungus
10/10/2001CN1316511A Process and equipment for preparing liquid strain of edible fungus
10/10/2001CN1316510A Artificially cultured edible tree fungi strain and its production method
10/10/2001CN1316509A Industrial cultivation of cordyceps sinensis sprocarp
10/10/2001CN1316432A Cell death inhibitory albumen
10/10/2001CN1072726C Detection of fungal pathogens using polymerase chain reaction
10/10/2001CN1072720C Chicken growth hormone gene and expression thereof in E. Coli
10/10/2001CN1072718C Lipase and its micro-organism process for producing the lipase, and use
10/10/2001CN1072650C Bibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agent
10/10/2001CN1072457C Health food mushroom essence and its preparing method
10/09/2001US6300544 Cytochrome P450 monooxygenases
10/09/2001US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease
10/09/2001US6300484 DNA encoding DP. 75 and a process for its use
10/09/2001US6300474 Modified interferons
10/09/2001US6300472 Rab proteins
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6300130 Ultra rapid freezing for cell cryopreservation
10/09/2001US6300127 Bone mineralization proteins, DNA, vectors, expression systems
10/09/2001US6300120 Phage with nuclear localization signal
10/09/2001US6300119 Stretococcal ERS
10/09/2001US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome
10/09/2001US6300117 Proteases from gram-positive organisms
10/09/2001US6300116 Modified protease having improved autoproteolytic stability
10/09/2001US6300112 β-xylosidase, nucleotide sequence encoding it, and use thereof
10/09/2001US6300103 A protein isolated from sugar beets; fungicides, viricides, herbicide resistance, nematode resistance, bacteriocides
10/09/2001US6300100 Process for preparing tissue factor pathway inhibitor
10/09/2001US6300098 Human signal transduction serine/threonine kinase
10/09/2001US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders
10/09/2001US6300095 A dna fragment used for blocking genetic expression through antisense constructs and for increased antibiotic production
10/09/2001US6300094 Polynucleotides encoding a novel ABC transporter
10/09/2001US6300092 Methods of use of a novel lysyl oxidase-related protein
10/09/2001US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
10/09/2001US6300065 Anchoring polypeptides to yeast cell wall accesible for protein-protein binding along with fluorescence activated cell sorting for selecting cells exhibiting a variegated population of mutant proteins
10/09/2001US6300064 Protein/(poly)peptide libraries
10/09/2001US6300062 Enamel matrix related polypeptide
10/09/2001US6299877 Used in therapy
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001CA2179656C Chromosomal expression of heterologous genes in bacterial cells
10/09/2001CA1341303C Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (adcc) treatment of cancer and other diseases
10/09/2001CA1341301C Preparation of functional human urokinase proteins
10/09/2001CA1341300C Recombinant dna means and method for producing bovine rennin and precursors
10/05/2001CA2340300A1 Nucleotide sequences that code for the rplk gene and methods of use thereof
10/04/2001WO2001073108A2 A bacterial two-hybrid system for protein interaction screening
10/04/2001WO2001073099A1 A method for enhancing levels of polyunsaturated fatty acids in thraustochytrids
10/04/2001WO2001073096A1 Enhanced production of secondary metabolites in the presence of organic additives
10/04/2001WO2001073093A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
10/04/2001WO2001073086A2 Method for genetically modifying a plant
10/04/2001WO2001073083A2 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use
10/04/2001WO2001073082A2 Methods and cells for expression of recombinant protein products
10/04/2001WO2001073081A1 Escherichia coli strain secreting human granulocyte colony stimulating factor (g-csf)
10/04/2001WO2001073080A2 Recombinant iron uptake proteins
10/04/2001WO2001073075A2 Muskmelon cucumis melo hydroperoxide lyase and uses thereof
10/04/2001WO2001073052A2 Thermophilic polymerase iii holoenzyme
10/04/2001WO2001073039A1 Mutants of lactobacillus casei defective in carbon catabolism regulation
10/04/2001WO2001073038A2 Method for the biotechnological production of l-alaninol
10/04/2001WO2001073037A2 R5 protein, a cell-surface protective antigen of group b streptococci
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073023A1 Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same
10/04/2001WO2001073021A1 Novel g protein-coupled receptor protein and dna thereof
10/04/2001WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation)
10/04/2001WO2001073015A1 Identification of human gaba transporter
10/04/2001WO2001073014A1 Human survivin interacting protein 1 (sip-1)
10/04/2001WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
10/04/2001WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001WO2001072968A1 Chlamydospores and process for producing the same
10/04/2001WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001WO2001072961A2 Novel compounds
10/04/2001WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072829A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
10/04/2001WO2001072781A2 Human genes and expression products
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072768A2 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
10/04/2001WO2001072336A1 Compounds for targeting
10/04/2001WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001WO2001072131A1 A method for preventing plant disease
10/04/2001WO2001048227A8 Method for production of proteins in host cells involving the use of chaperonins
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001019955A3 Lysosomal targeting pathway enzymes
10/04/2001WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis
10/04/2001WO2001016334A3 Human hydrolytic enzymes
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
1 ... 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 ... 1489